Patents Assigned to McNeilabs, Inc.
  • Patent number: 4732675
    Abstract: A filtration unit comprising a filtration media subunit secured in an outer frame. The subunit comprises a fibrous filtration media enclosed in an inner frame having an upstream frame element and a downstream frame element. Each frame element has longitudinal and transverse struts and the intersection of these struts is in a single plane on the side of the frame elements which contact the filtration media. In one embodiment the filtration unit is enclosed in a sock of knit fabric; in another embodiment, there is a piece of knit fabric between the outer frame and the downstream frame element of the inner frame. The longitudinal struts may have portions which are perpendicular to and project beyond the principal plane of the periphery of the downstream frame element. If such perpendicularly projecting portions are provided, they are preferably arcuate in configuration.
    Type: Grant
    Filed: August 7, 1986
    Date of Patent: March 22, 1988
    Assignee: McNeilab, Inc.
    Inventors: Anthony Badolato, Melissa A. Prince
  • Patent number: 4731072
    Abstract: Apparatus for heating or cooling fluids, particularly physiological fluids such as blood or plasma or fluids, such as dialysis fluid, which are used in the treatment of physiological fluids. Also disclosed are containers in which or through which fluids may be contained or circulated in order to effect heating or cooling.
    Type: Grant
    Filed: July 2, 1982
    Date of Patent: March 15, 1988
    Assignee: McNeilab, Inc.
    Inventor: James D. Aid
  • Patent number: 4729994
    Abstract: N-Aminoalkyl 1,5-benzothiazepines of the following formula (I): ##STR1## for the treatment of angina or hypertension or the prevention of heart attacks in mammals, in particular their use as coronary vasodilators.
    Type: Grant
    Filed: March 16, 1987
    Date of Patent: March 8, 1988
    Assignee: McNeilab, Inc.
    Inventor: John R. Carson
  • Patent number: 4728666
    Abstract: Heterocyclic acetylenes of the formula (I): ##STR1## wherein Y and R.sup.1 are substituents such as hydrogen, alkyl, alkoxy, chloro or fluoro, m is 0-2, R.sup.2 is branched alkyl and Het is an aromatic heterocycle. The acetylenes are useful in treating hypertension and/or angina.
    Type: Grant
    Filed: November 24, 1986
    Date of Patent: March 1, 1988
    Assignee: McNeilab, Inc.
    Inventor: John R. Carson
  • Patent number: 4727072
    Abstract: Propylamines of the formula (I): ##STR1## and isomers thereof, particularly those enantiomers and racemates relative to the chiral carbon indicated by an asterisk (*). The propylamines can be used for the treatment of hypertension or angina in humans. A is pyrrolidine, piperidine or morpholine and B is an aromatic heterocycle, aromatic carbocycle or saturated carbocycle.
    Type: Grant
    Filed: February 12, 1986
    Date of Patent: February 23, 1988
    Assignee: McNeilab, Inc.
    Inventors: Philip P. Grous, Richard J. Mohrbacher
  • Patent number: 4725604
    Abstract: Various indole and benzothiophene compounds having a pendant pyrrolidinylidene amino or piperidinylideneamino group are useful in the prevention of ventricular fibrillation, e.g., in humans. The invention comprises methods for the treatment of ventricular dysrhythmia or the prevention of ventricular fibrillation.
    Type: Grant
    Filed: March 7, 1986
    Date of Patent: February 16, 1988
    Assignee: McNeilab, Inc.
    Inventors: William E. Hageman, Michael J. Zelesko
  • Patent number: 4725602
    Abstract: Acetylenes of the following formula (I): ##STR1## wherein Y, m, R.sup.1, R.sup.2, R.sup.3, n and R.sup.4 are defined herein and R.sup.5 is hydrogen, alkyl, cycloalkyl or substituted alkyl are useful vasodilators and antihypertensives.
    Type: Grant
    Filed: October 24, 1985
    Date of Patent: February 16, 1988
    Assignee: McNeilab, Inc.
    Inventor: John R. Carson
  • Patent number: 4719216
    Abstract: Novel compounds are disclosed, which are derivatives of 1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]-isoquinolines, represented by general formula (I): ##STR1## as well as pharmaceutical compositions and methods for the treatment of depression in warm-blooded animals, e.g., man. Novel intermediates are also part of the invention.
    Type: Grant
    Filed: March 14, 1986
    Date of Patent: January 12, 1988
    Assignee: McNeilab, Inc.
    Inventor: Bruce E. Maryanoff
  • Patent number: 4716163
    Abstract: Pyrrolidinylidene compounds substituted at the 5-position of the following formula (I): ##STR1## wherein R=H, alkyl or alkanoyl, and their use as hypoglycemic agents, e.g. in the treatment of diabetes, in a manner similar to linogliride.
    Type: Grant
    Filed: April 3, 1987
    Date of Patent: December 29, 1987
    Assignee: McNeilab, Inc.
    Inventors: Joyce E. Epps, Kung-Tat Ng, Robert W. Tuman, Wu-Nan Wu
  • Patent number: 4716172
    Abstract: Octahydroquinolizine and corresponding octahydroquinolizinium compounds of formulae (I) and (Va): ##STR1## where A is a 3 to 7 membered carbocyclic ring, R.sup.1 is a substituent, n is 0-2, x is 0-3, and Y is an anion. Also, pharmaceutical compositions for treating pain containing (I) and methods for synthesis and use as well as novel intermediates in the synthesis.
    Type: Grant
    Filed: April 10, 1986
    Date of Patent: December 29, 1987
    Assignee: McNeilab, Inc.
    Inventors: Richard J. Carmosin, John R. Carson
  • Patent number: 4713386
    Abstract: Tetrahydroazeto[2,1-a]isoquinoline of the formula (I): ##STR1## wherein R, R.sup.1, R.sup.2 and R.sup.3 are substituents and x and y are 0-2. Also pharmaceutical compositions for relieving depression in mammals, e.g. in humans, and methods for synthesis and use of formula (I) compounds as well as novel intermediates in the synthesis.
    Type: Grant
    Filed: September 22, 1986
    Date of Patent: December 15, 1987
    Assignee: McNeilab, Inc.
    Inventor: Bruce E. Maryanoff
  • Patent number: 4708715
    Abstract: A removable U.V. light array assembly for use in a photoactivatable agent, patient treatment system wherein photoactivatable agents, in contact with patient blood cells, are irradiated extracorporeally and then returned to the patient.
    Type: Grant
    Filed: February 27, 1986
    Date of Patent: November 24, 1987
    Assignee: McNeilab, Inc.
    Inventors: Vernon H. Troutner, Martin J. King
  • Patent number: 4705498
    Abstract: There is provided an inexpensive disposable temperature monitoring probe for use in a patient treatment system wherein photoactivatable agents, in contact with patient cells, are irradiated extracorporeally to photoactivate said agents and then returned to the patient.
    Type: Grant
    Filed: February 27, 1986
    Date of Patent: November 10, 1987
    Assignee: McNeilab, Inc.
    Inventor: Jack Goss
  • Patent number: 4693850
    Abstract: Novel synthetic steps and intermediates leading to guanidines such as the anti-diabetic compound linogliride.
    Type: Grant
    Filed: November 26, 1986
    Date of Patent: September 15, 1987
    Assignee: McNeilab, Inc.
    Inventors: Cynthia A. Maryanoff, James N. Plampin, Robin C. Stanzione
  • Patent number: 4692460
    Abstract: Cyclopenta[b]thiophenes of the following formulae (I) and (II): ##STR1## wherein R.sup.1 and R.sup.4 are H or alkyl and R.sup.2, R.sup.3, R.sup.5 andR.sup.6 are alkyl, as well their salts, are anti-inflammatory agents having pharmacological profiles similar to that of steroids. Also part of the invention are pharmaceutical compositions and methods for the pharmaceutical treatment of mammals such as man.
    Type: Grant
    Filed: December 24, 1986
    Date of Patent: September 8, 1987
    Assignee: McNeilab, Inc.
    Inventor: John R. Carson
  • Patent number: 4692138
    Abstract: Pump block for interfacing an irradiation chamber with a roller pump in an apparatus for use in a photoactivatable agent, patient treatment system wherein photoactivatable agents, in contact with patient blood cells, are irradiated extracorporeally and then returned to the patient.
    Type: Grant
    Filed: February 27, 1986
    Date of Patent: September 8, 1987
    Assignee: McNeilab, Inc.
    Inventors: Vernon H. Troutner, Martin J. King
  • Patent number: 4689329
    Abstract: Octahydroindolizidines and corresponding ketones of the formulae (I) and (II): ##STR1## where A is a 3-7 carbon or hetero-containing ring, R.sup.1 is a substituent, n is 0-6 and x is 0-3. Also, pharmaceutical compositions for treating pain containing (I) or (II) and methods for synthesis and use as well as novel intermediates in the synthesis.
    Type: Grant
    Filed: February 4, 1986
    Date of Patent: August 25, 1987
    Assignee: McNeilab, Inc.
    Inventors: Richard J. Carmosin, John R. Carson
  • Patent number: 4687464
    Abstract: Automatic operating zero insertion force socket for use in a photoactivatable reagent treatment system wherein photoactivatable agents, in contact with patient blood cells, are irradiated extracorporeally and then returned to the patient.
    Type: Grant
    Filed: February 27, 1986
    Date of Patent: August 18, 1987
    Assignee: McNeilab, Inc.
    Inventor: Vernon H. Troutner
  • Patent number: 4683239
    Abstract: Octahydroindolizine compounds of formula (I): ##STR1## wherein Q is --NR--, --(CH.sub.2).sub.z --, --CH.dbd.CH--, --C.tbd.C--, --OCH.sub.2 --, --SCH.sub.2 --, --SO.sub.2 --, --SO--, --CO--, or an oxygen or a sulfur atom and where R, R.sup.1 and R.sup.2 are substituents such as alkyl and x, y and z are independently the integers 0-3. Also, pharmaceutical compositions containing (I), intermediates and methods for treating pain.
    Type: Grant
    Filed: April 10, 1986
    Date of Patent: July 28, 1987
    Assignee: McNeilab, Inc.
    Inventors: Richard J. Carmosin, John R. Carson
  • Patent number: 4681568
    Abstract: Manually overridable servo controlled valve mechanisms for controlling the flow of fluids through a flexible tube for use in a photoactivatable agent treatment system wherein photoactivatable agents, in contact with patient blood cells, are irradiated extracorporeally and then returned to the patient.
    Type: Grant
    Filed: February 27, 1986
    Date of Patent: July 21, 1987
    Assignee: McNeilab, Inc.
    Inventor: Vernon H. Troutner